Innovent Biologics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 35.42 | -100% | -40.75 | -100% |
| P/S |
|
9.16 | 7.59 | 20.68% |
|
|
| P/BV |
|
4.54 | 3.68 | 23.1% |
|
|
| P/FCF |
|
-41.17 | 55.3 | -174.45% |
|
|
| Ev/Ebitda |
|
-29.88 | 2.91 | -1127.39% |
|
|
| Ev/S |
|
9.28 | 23.72 | -60.86% |
|
|
| Ev/FCF |
|
-46.62 | 63.78 | -173.09% |
|
|
| E/P |
|
-0.0202 | 0.0326 | -161.9% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-38.39 | -11.9 | 222.56% | -3195.81 | -98.8% |
| ROE |
|
-8.84 | 5.19 | -270.43% |
|
|
| ROA |
|
-5.38 | 3.47 | -255.05% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-16.56 | -11.49 | 44.16% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.85 | 0.7755 | -338.1% | -4.17 | -55.71% |
| Nеt Debt/Ebitda |
|
-0.4437 | 0.0127 | -3585.29% |
|
|
| Debt/Ratio |
|
0.1566 | 0.1229 | 27.46% |
|
|
| Debt/Equity |
|
0.7956 | 0.802 | -0.8004% |
|
|
| Debt/Net Income |
|
-3.14 | 1.76 | -278.79% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.13 | -100% | ||
| DSI |
|
0 | 0.5838 | -100% |
|
|
| Average dividend growth |
|
0 | 3.2 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 4.95 | -100% |
|
|
| Average percentage for payments |
|
0 | 23.96 | -100% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
492.45 | 28.69 | 1616.45% | ||
| Growth impulse Ebitda in 5 years |
|
17.52 | -40.52 | -143.24% | ||
| Growth impulse Net Income in 5 years |
|
-40.24 | 94.84 | -142.43% | ||
| Growth impulse FCF in 5 years |
|
-39.14 | 91.41 | -142.82% | ||
| Growth impulse EPS in 5 years |
|
336.2 | -118.14 | -384.58% |
IP Score
3.36/10
